Skip to main content

Together we are beating cancer

Donate now

Cancer News

Science & Technology

Read the latest in pre-clinical research, drug discovery and new technologies in cancer
Showing 12 out of 1581 results
Colourful lollipops on a pink background.

Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably. Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably.

by Yvonne Ijeh, Tim Gunn | Analysis | 25 October 2024

25 October 2024

This entry is part 2 of 6 in the series Stand Up To Cancer
%postcontent%
Yinka and Kola Bokinni holding Stand Up To Cancer donation jars

Every two years we fund exciting new projects through the Stand Up To Cancer (SU2C) campaign. Learn more about SU2C and some of our previous research projects in this new SU2C series. Every two years we fund exciting new projects through the Stand Up To Cancer (SU2C) campaign. Learn more about SU2C and some of our previous research projects in this new SU2C series.

by Nisharnthi Duggan | Analysis | 24 October 2024

24 October 2024

This entry is part 1 of 6 in the series Stand Up To Cancer
%postcontent%
Brain scans

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

by Sophie Wedekind | News | 23 October 2024

23 October 2024

3D image of blood vessels in the hand, taken using a photoacoustic tomography scanner.

A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time. A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time.

by Sophie Wedekind | News | 15 October 2024

15 October 2024

Microscopic image of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

by Fiona Scott | News | 1 October 2024

1 October 2024

Radiographer looking at a mammogram image

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

by Amy Warnock | In depth | 1 October 2024

1 October 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024

scientists in a lab

Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

Microscopy image of Hodgkin's lymphoma

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

by Cancer Research UK | In depth | 3 September 2024

3 September 2024